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Introduction
Epidemiological studies have shown that chronic 
rhinosinusitis (CRS) affects 10%–15% of the peo-
ple in the United States with peaks between 30 and 
60 years of age. CRS is characterised by mucosal 
inflammation of the nose and paranasal sinuses and 
can be divided into two broad clinical categories: 
CRS with and without nasal polyposis.
The most widely used means of treating CRS 
are topical nasal sprays, oral steroids and antibiot-
ics, and saline nasal irrigations (SNIs), which is 
often recommended for CRS patients in everyday 
Saline nasal irrigations for chronic 
rhinosinusitis: From everyday practice  
to evidence-based medicine. An update
Manuele Casale1, Antonio Moffa2, Michele Cassano2,  
Francesco Carinci3, Michele Antonio Lopez4,  
Eleonora Maria Consiglia Trecca2, Sara Torretta5 ,  
Vittorio Rinaldi1 and Lorenzo Pignataro5
Abstract
Saline nasal irrigations (SNIs) are often recommended as an additional non-pharmacological treatment for adults with 
chronic rhinosinusitis (CRS), for which it could even be considered a first-line treatment. However, there is a wide 
range of different SNI protocols. The aim of this article is to review the published literature regarding all of the potential 
therapeutic effects of SNIs in adult CRS patients who had not undergone sinus surgery and clarify the role of the various 
saline nasal solutions and protocols (particularly the volume, frequency and duration of treatment), and describe the 
nasal devices used. A search was made of the PubMed, Google Scholar and Ovid databases using the key words ‘saline 
nasal irrigation’ and ‘chronic rhinosinusitis’, or medical subject headings. The search identified 11 studies involving 663 
patients. There was no consensus about but substantial agreement concerning the frequency and duration of treatment, 
the type of device, and the amount of solution to be used when managing CRS. A hypertonic solution with the addition 
of the natural minerals and oligo-elements found in seawater and some thermal waters may be associated with greater 
clinical benefit in terms of endoscopic scores and mucociliary clearance than isotonic solutions. Further studies are 
required to compare the different forms of SNI and define SNI protocols and nasal devices, while considering patient 
compliance.
Keywords
chronic rhinosinusitis, hypertonic solution, isotonic solution, saline nasal irrigation
Date received: 14 June 2018; accepted: 28 August 2018
1 Department of Otolaryngology, Campus Bio-Medico University, 
Rome, Italy
2Department of Otolaryngology, University of Foggia, Foggia, Italy
3 Department of Morphology, Surgery and Experimental Medicine, 
University of Ferrara, Ferrara, Italy
4University of the Republic of San Marino, San Marino, San Marino
5 Department of Otolaryngology and Department of Clinical Sciences 
and Community Health, Fondazione IRCCS Ca’ Granda Ospedale 
Maggiore Policlinico, University of Milan, Milan, Italy
Corresponding author:
Antonio Moffa, Department of Otolaryngology, University of Foggia, 
Viale Pinto, 1. 71122, Foggia, Italy. 
Email: moffa.antonio1@gmail.com
802676 IJI0010.1177/2058738418802676International Journal of Immunopathology and PharmacologyCasale et al.
letter2018
Letter to the Editor
2 International Journal of Immunopathology and Pharmacology 
clinical practice. SNIs are most frequently carried 
out using isotonic or hypertonic saline or seawater 
solutions, and typically improve nasal mucosa 
function as a result of direct mucosal cleansing; the 
removal of antigens, biofilms or inflammatory 
mediators (thus resolving inflammation) and 
improved mucociliary function.
However, SNI protocols vary widely in terms of 
the volume, frequency and duration of treatment, 
and nasal devices used. A 2016 Cochrane review 
concluded that a low-volume (5 mL) nebulised 
saline spray offered no benefit over intranasal ster-
oids, but that daily, large-volume (150 mL) irriga-
tions with a hypertonic saline solution were more 
beneficial than placebo, although the quality of the 
evidence was low. However, as this review gave no 
information concerning tonicity, volume, delivery, 
frequency or duration of use, and included only 
two very small, open-label and clinically heteroge-
neous studies with major limitations, it is difficult 
to draw any practical conclusions.1
The aims of this review were to verify the effec-
tiveness of SNIs in CRS patients using the criteria 
of evidence-based medicine and clarify the roles of 
the various saline solutions; the volume, frequency 
and duration of treatment; and the types of nasal 
devices.
Methods
Search strategy and article selection process
A search was made of the PubMed, Google Scholar 
and Ovid databases in accordance with the PRISMA 
guidelines using the following key words or (in the 
case of PubMed) medical subject headings: ‘nasal 
washes’, ‘nasal irrigation’, ‘nasal douche’, ‘saline 
nasal irrigation’, ‘saline solution’, ‘sodium chloride 
solution’, ‘isotonic solution’, ‘hypertonic solution’, 
‘thermal water solution’, ‘seawater solution’ and 
‘chronic rhinosinusitis’.
The main eligibility criteria were English-
language articles, randomised and controlled trials 
in humans and the effect size of SNI evaluated 
clinically in patients with CRS symptoms who had 
not undergone sinus surgery. There were no 
restrictions in terms of date of publication or study 
duration, but retrospective studies, literature 
reviews, technical notes, letters to editors and 
instructional courses were excluded, as were pae-
diatric studies, studies that simultaneously consid-
ered episodes of acute and CRS, and studies of the 
use of SNI following endoscopic sinus surgery. 
Additional literature was found by reviewing the 
reference lists of the selected articles. The authors 
then independently assessed the full-text versions 
of each publication and excluded those whose 
content was judged not to be strictly related to the 
subject of this review.
Results
Analysis of the literature
The search initially identified 24 potentially rele-
vant studies but, after excluding five studies con-
cerning the addition of corticosteroids, antibiotics, 
antifungals or polysaccharides to normal saline 
solution, six paediatric studies, one study of cystic 
fibrosis, and one study of acute and CRS, the final 
analysis was based on 11 studies involving a total 
of 663 patients (Figure 1): eight clinical trials com-
paring different saline solutions and three compar-
ing the effects of nasal solutions delivered by 
means of different devices.
Clinical studies of the therapeutic effects of 
different saline nasal solutions
Thermal water solution versus isotonic saline solution. Otta-
viano et al.2 evaluated the effects of 30 days’ SNI 
on 70 smokers with non-allergic CRS: 35 treated 
with sulphurous–arsenical–ferruginous thermal 
water and 35 treated with an isotonic saline solu-
tion. During the follow-up, all of the participants 
Figure 1. Flow chart of study selection process.
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underwent n-butanol olfactory threshold tests, 
nasal cytology, active anterior rhinomanometry 
and nasal endoscopy.
The group treated with thermal water showed a 
statistical trend towards lower nasal resistances 
and significantly greater improvements in the num-
ber of ciliated cells and nasal endoscopy results 
after 1 month, but the olfactory threshold was sig-
nificantly higher in the group treated with the iso-
tonic saline solution.
Sulphurous, salty, bromic, iodic thermal water versus isotonic 
saline solution. Ottaviano et al.3 compared the effects 
of 30 days’ SNI on 80 CRS patients: 40 treated 
with sulphurous, salty, bromic, iodic (SSBI) ther-
mal water and 40 treated with an isotonic saline 
solution. Upon enrolment and at the end of the 
treatment, the patients provided microbiological 
nasal swabs and underwent anterior active rhi-
nomanometry and nasal endoscopy.
Nasal endoscopy showed a significant clinical 
improvement in both groups at the end of the treat-
ment, and there were no signs of bacteria, but only 
the SSBI water irrigations significantly reduced 
total nasal resistance.
Hypertonic versus isotonic seawater solution. Culig 
et al.4 compared the efficiency of 15 days’ treat-
ment with a 0.9% isotonic or a 2.12% hypertonic 
seawater solutions in 60 CRS patients (30 in 
each group). Both solutions contained trace 
amounts of natural minerals and oligo-elements, 
but the hypertonic solution was enriched with 
monohydrated manganese and pentahydrated 
copper salts. The patients were asked to write 
notes concerning their sinonasal symptoms and 
to self-complete a quality of life questionnaire 
covering the quality of sleep, and their daily 
activities and emotions. The hypertonic solution 
was significantly better, especially in terms of 
nasal congestion, rhinorrhea, cough, headache 
and waking up during the night.
Buffered isotonic solution versus buffered hypertonic solution. 
Hauptman and Ryan5 compared the effects of sin-
gle administrations of 1 mL of buffered isotonic 
solution (0.9%) or buffered hypertonic solution 
(3%) delivered by means of a standard nasal spray 
on 80 CRS patients (40 in each group). Before and 
after the treatment, the patients were interviewed 
about their main nasal symptoms and underwent 
anterior rhinomanometry and saccharine clearance 
tests.
Both solutions significantly improved nasal 
symptoms and mucociliary clearance, which was 
greater after the administration of the hypertonic 
solution. However, the hypertonic solution had no 
effect on nasal patency, which was increased by the 
isotonic solution.
Dead Sea salt solution versus hypertonic saline solu-
tion. Friedman et al.6 investigated the effects of 
60 days’ treatment with a 1.8% hypertonic Dead 
Sea salt solution (DSS, 22 patients) or an 1.8% 
hypertonic saline solution (20 patients). Before 
enrolment and 30 days after treatment, all of the 
patients underwent anterior rhinoscopy and nasal 
endoscopy and completed a 16-point rhinitis symp-
tom questionnaire and the standardised Rhinocon-
junctivitis Quality of Life Questionnaire 
(RQLQ(S)). SNI with DSS significantly improved 
rhinitis symptoms and RQLQ(S) scores in com-
parison with the hypertonic saline solutions.
Hypertonic SNI using 2% buffered saline in a SinuCleanse 
nasal cup. Rabago et al.7 investigated the efficacy 
of hypertonic saline nasal irrigation (HSNI) in 
54 CRS patients: 40 treated with HSNI using 2% 
buffered saline in a SinuCleanse nasal cup and 
14 not undergoing nasal washes. During the fol-
low-up, clinicians used the Rhinosinusitis Disa-
bility Index (RSDI), a sinus-symptom severity 
assessment (SIA) and the Sino-Nasal Outcomes 
Test 20 (SNOT-20) and evaluated the frequency 
and pattern of HSNI, its side effects and the 
patients’ satisfaction.
In the HSNI group, RSDI scores continued to 
improve, while SIA and SNOT-20 scores remained 
stable. HSNI was used for a mean of 2.4 irriga-
tions per week; 33% of the patients used HSNI 
regularly, and 55% when symptomatic. There 
were only minor side effects, and patient satisfac-
tion was high.
Daily hypertonic SNI improves sinus-related quality of life and 
decreases medication use. Rabago et al.8 evaluated the 
efficacy of daily hypertonic SNI for 6 months in 52 
CRS patients and compared the results with those 
observed 24 CRS patients not undergoing SNI. Cli-
nicians administered the short form of the Medical 
Outcomes Survey (SF-12), the RSDI and the single-
item sinus-symptom severity assessment (SIA) and 
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assessed compliance daily, and symptoms and the 
use of medication every 2 weeks.
The RSDI and SIA scores in the SNI group 
improved in comparison with the control group, 
and the subjects reported fewer 2-week periods 
with sinus-related symptoms and used antibiotics 
and nasal sprays less frequently.
Ems salt solution versus isotonic saline solution. Bachmann 
et al.9 compared the effectiveness of 7 days’ SNI 
using Ems salt thermal water (1.1%, and rich in 
Rb+, Cs+, Ba2+, Mn2+, and Sr2+) in 20 CRS 
patients and isotonic saline solution in 20 CRS 
patients. All of the subjects underwent nasal endos-
copy, plain radiography of the paranasal sinuses, 
olfactometry, anterior rhinomanometry and a sac-
charin-clearance test on days 1 and 7, and the 
patients kept a diary in which to record general dis-
comfort, nasal airway obstruction, and the use of 
additional nasal spray.
Olfactometry, saccharine clearance and rhi-
nomanometry values were slightly but non-signifi-
cantly better in the Ems salt solution groups than in 
the controls. General discomfort improved in both 
groups, but the control group more frequently 
required the additional use of decongestive nasal 
sprays.
Clinical studies of the therapeutic effects of 
different means of administration
Large-volume isotonic SNI at low positive pressure versus iso-
tonic spray. Pynnonen et al.10 compared the effects 
of 8 weeks of treatment with a large volume of iso-
tonic SNI solution delivered at low positive pres-
sure (61 CRS patients) with those of isotonic sprays 
(60 patients). Clinicians evaluated symptom sever-
ity using the SNOT-20, as well as symptom fre-
quency and changes in the use of medications.
The irrigation group had lower SNOT-20 
scores after 2, 4 and 8 weeks and showed a sig-
nificant reduction in symptom frequency in com-
parison with the control group. There was no 
significant between-group difference in the use 
of sinus medication.
SNI using a bulb syringe versus SNI using a nasal irrigation pot. 
Heatley et al.11 evaluated the therapeutic effects 
of SNI on CRS adult patients divided into three 
groups of 50 patients each: groups 1 and 2 under-
went daily hypertonic SNIs using a bulb syringe 
for 2 weeks followed by further 2 weeks using a 
nasal irrigation pot, or vice versa; group 3 did not 
undergo nasal irrigation. All of the patients com-
pleted pretreatment Medical Outcomes Study 
Short Form, pretreatment and posttreatment Rhi-
nosinusitis Outcomes Measure, and a record was 
made of their daily medication use, subjective 
judgements of treatment efficacy, and preferred 
irrigation method.
There was a significant and equivalent improve-
ment in RSOM31 score after 2 weeks of treatment 
in groups 1 and 2, and a total of 35% of the subjects 
reported a decrease in their use of decongestants, 
antihistamines, pain relievers, and nasal sprays, 
with no measurable difference between the three 
groups.
Alkaline nasal douche versus seawater spray. Taccariello 
et al.12 compared 8 weeks of treatment using an 
alkaline nasal douche with a 1:1 mixture of 
sodium chloride and sodium bicarbonate (19 
patients) or a sterile seawater spray (21 patients); 
a control group of 22 patients did not undergo 
nasal washes. At the beginning and end of the 
treatment period, the patients underwent rigid 
endoscopy and acoustic rhinometry, and nasal 
mucociliary clearance and ciliary beat frequency 
tests; they also completed a symptoms diary card 
and a quality of life questionnaire.
There were significant differences between the 
two treatment groups insofar as the alkaline nasal 
douche improved endoscopic findings but not 
quality of life scores, whereas the opposite was 
true for the spray. There were no significant 
between-group differences in the acoustic rhinom-
etry findings, diary card scores, nasal mucociliary 
clearance or ciliary beat frequency tests.
Discussion
Founded on everyday practice and common 
sense, SNI plays an essential role in the CRS 
medical treatment for the large majority of prac-
titioners. In this review, six studies evaluated the 
use of SNI once or twice a day, and two its use 
more than three times a day (Figure 2). Treatment 
duration varied from a single administration5 to 
6 months7,8 (Figure 3). Only four studies2,3,5,9 
specified the dose of the daily administrations. 
Two clinical trials used sprays, and six simply 
specified ‘irrigation’. Hauptman et al.5 and 
Casale et al. 5
Bachmann et al.9 found that hypertonic solutions 
improved mucociliary clearance better than iso-
tonic solutions, and Ottaviano et al.2 and 
Bachmann et al.9 observed that they also led to a 
greater improvement in nasal resistance as 
assessed by means of active anterior rhinoma-
nometry. Hypertonic seawater solutions also pro-
vided significantly better symptom relief in terms 
of nasal congestion, rhinorrhea, cough and head-
ache than isotonic solutions.4,5
Despite the heterogeneity of the studies, there 
was a trend towards the conclusion that the once- 
or twice-daily administration of a hypertonic 
solution with the addition of the natural minerals 
and oligo-elements found in seawater and some 
thermal waters may be associated with a greater 
clinical benefit, better endoscopic scores 
and improved nasal resistance than isotonic 
solutions.2-6
SNI is inexpensive, can be performed at home 
and is a good treatment option for many patients. It 
is rarely accompanied by adverse effects, although 
the use of hypertonic solutions can lead to the 
irritation of nasal mucosa and a greater sensation 
of burning.5 The findings of the studies of different 
delivery methods and devices were somewhat 
conflicting.
In conclusion, the few studies of the use of SNI 
in CRS patients are characterised by a small patient 
populations, short observation periods and differ-
ent clinical and diagnostic parameters evaluated. 
More studies are required to identify the best means 
of administration (spray, syringe, nasal pot, spray-
sol, etc.) and the best treatment schedule. The close 
connection between particle diameter and high 
concentrations of nebulised particles in the upper 
aero-digestive tract suggests the need to choose 
nebulisers carefully in order to obtain better thera-
peutic results. Tailored SNI for CRS patients 
should not only consider the solution used, the 
most suitable device, and the most appropriate 
treatment schedule, but also patient compliance, 
which is crucial in the case of daily treatment for a 
chronic inflammatory disease such as CRS.
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